HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sleep apnea determines soluble TNF-α receptor 2 response to massive weight loss.

AbstractBACKGROUND:
The effects of surgical weight loss (WL) on inflammatory biomarkers associated with sleep apnea remain unknown. We sought to determine if any biomarkers can predict amelioration of sleep apnea achieved by bariatric surgery. We hypothesized that surgical WL would substantially reduce severity of sleep apnea and levels of proinflammatory cytokines.
METHODS:
Twenty-three morbidly obese adults underwent anthropometric measurements, polysomnography, and serum biomarker profiling prior to and 1 year following bariatric surgery. We examined the effect of WL and amelioration of sleep apnea on metabolic and inflammatory markers.
RESULTS:
Surgical WL resulted in significant decreases in BMI (16.7 ± 5.97 kg/m(2)/median 365 days), apnea-hypopnea index (AHI), CRP, IL-6, sTNFαR1, sTNFαR2, and leptin levels, while ghrelin, adiponectin, and soluble leptin receptor concentrations increased significantly. Utilizing an AHI cutoff of 15 events/h, we found significantly elevated levels of baseline sTNFαR2 and greater post-WL sTNFαR2 decreases in subjects with baseline AHI ≥15 events/h compared to those with AHI <15 events/h despite no significant differences in baseline BMI, age, and ΔBMI. In a multivariable linear regression model adjusting for sex, age, impaired glucose metabolism, ΔBMI, and follow-up period, the post-WL decreases in AHI were an independent predictor of the decreases in sTNFαR2 and altogether accounted for 46% of the variance of ΔsTNFαR2 (P = 0.011) in the entire cohort.
CONCLUSIONS:
Of all the biomarkers, the decrease in sTNFαR2 was independently determined by the amelioration of sleep apnea achieved by bariatric surgery. The results suggest that sTNFαR2 may be a specific sleep apnea biomarker across a wide range of body weight.
AuthorsMaria Pallayova, Kimberley E Steele, Thomas H Magnuson, Michael A Schweitzer, Philip L Smith, Susheel P Patil, Shannon Bevans-Fonti, Vsevolod Y Polotsky, Alan R Schwartz
JournalObesity surgery (Obes Surg) Vol. 21 Issue 9 Pg. 1413-23 (Sep 2011) ISSN: 1708-0428 [Electronic] United States
PMID21298510 (Publication Type: Clinical Trial, Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Adipokines
  • Biomarkers
  • Receptors, Tumor Necrosis Factor, Type II
Topics
  • Adipokines (blood)
  • Adiposity
  • Adult
  • Bariatric Surgery
  • Biomarkers (blood)
  • Body Mass Index
  • Female
  • Humans
  • Linear Models
  • Longitudinal Studies
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Obesity, Morbid (blood, complications, physiopathology, surgery)
  • Polysomnography
  • Receptors, Tumor Necrosis Factor, Type II (blood)
  • Sex Factors
  • Sleep Apnea Syndromes (blood, complications)
  • Treatment Outcome
  • Weight Loss

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: